Phase 2 Sleep Disorders Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have moderate-to-severe obstructive sleep apnea, meaning their sleep study showed 15 or more breathing interruptions per hour

Who may not be able to join:

• People who have a serious disease affecting a major organ (such as the heart, lungs, or kidneys) that would interfere with the study's measurements
• People who take medications known to speed up or slow down breathing, such as opioids, barbiturates, acetazolamide, doxapram, almitrine, theophylline, 4-hydroxybutanoic acid, or similar drugs
• People who take antidepressants known as SNRIs or SSRIs
• People who have conditions that may affect sleep apnea in specific ways, including neuromuscular disease, major neurological disorders, heart failure, or other unstable serious medical conditions
• People who have breathing or sleep-related conditions other than obstructive sleep apnea
• People who have other sleep disorders such as periodic limb movement disorder (more than 10 movement-related wake-ups per hour), narcolepsy, or parasomnias (such as sleepwalking)
• People who have had a severe allergic reaction — such as severe swelling or hives — to the study drug
• People who have a medical reason that means they cannot safely take the study drug, DAW2020 (confirm with trial site)
• People who take medications known to affect the heart's electrical rhythm in a specific way (prolonging the QTc interval)
• People with low potassium levels, low magnesium levels, or poorly controlled thyroid disease
• People with severe claustrophobia

Important: Always verify eligibility with the trial site directly before applying.